Highlights
- 1Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022
- 2Bioinformatics (Oxford, England) · 2022
- 3npj metabolic health and disease · 2024
Publications
147 publications
Funding
16 grantsView NIH portfolio on RePORTER ↗
Active
9 grants- Sub-PIU19AG074879-03Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populationsNational Institute on Aging · 2023–2028 · via Duke University
- PIR01AG069901-05S1TargetAD: A systems multi-omics approach to drug repositioning in Alzheimer's diseaseNational Institute on Aging · 2021–2027· 3 renewals
- MPIT32HD113301-04Advanced Training in Artificial Intelligence for Precision Nutrition Science Research (AIPrN) Institutional Research TraiEunice Kennedy Shriver National Institute of Child Health and Human Development · 2025–2027 · via Cornell University - IthacaTraining
- Co-ISAC210104Weight management, metabolomics signatures and breast cancer risk and survivalSusan G. Komen Breast Cancer Foundation, Inc. · 2025–2027
- Co-IR01CA270243-01A1Therapeutic Targeting of SIRT3 for Aggressive and Refractory LymphomasNational Cancer Institute · 2023–2027
- Co-IR01AG076234-01Computational Drug Repurposing for AD/ADRD with Integrative Analysis of Real World Data and Biomedical KnowledgeNational Institute on Aging · 2022–2027
- Co-I21CHAL08Metabolic and Inflammatory Response to a Whole Food Plant-Based Diet in Overweight/Obese Men with Prostate Cancer Receiving Androgen Deprivation Therapy: A Phase II Randomized StudyProstate Cancer Foundation · 2022–2027
- Sub-PIU19AG063744-05The Alzheimer's Gut Microbiome ProjectNational Institute on Aging · 2019–2026 · via Duke University
- Co-IR21AG087400-01Uncovering Dementia-Related Lipid Alterations and Mechanisms in AstrocytesNational Institute on Aging · 2024–2026
Completed grants (7)
- Sub-PIU01AG061359-05Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-ADNational Institute on Aging · 2024–2025 · via Duke University
- PIR03CA252674-02Rational design of drug combinations to target chemotherapy resistance in high-grade serous ovarian cancer via metabolomic profiling of patient-derived organoidsNational Cancer Institute · 2021–2024
- Sub-PINPRP-S 12-0205-190042Cancer Metabolism: Target and Predictor of Therapeutic Intervention in Breast cancerQatar National Research Fund · 2020–2023 · via Weill Cornell Medical College/Qatar
- PISA 226681-01Deep learning multi-omics data analyses toolsWeill Cornell Medical College/Qatar · 2022–2022Contract
- Sub-PISA 204322-01Metabolomics data analysis of Alzheimer's Disease datasets in the ADMC consortiumNational Institutes of Health · 2020–2020 · via Duke UniversityContract
- Sub-PIDU 193337-01AMP AD Project B Biomarker Pilot Study: An integrated biomarker discovery pilot study (Broad/Rush-Emory-Duke)Foundation for the National Institutes of Health, Inc. · 2019–2019 · via Duke University
- Sub-PIR01AG046171-03Metabolic Networks and Pathways in Alzheimer's DiseaseNational Institute on Aging · 2018–2019 · via Duke University
News mentions
3 mentionsView all WCM news ↗
- Lowering Bioenergetic Age May Help Fend Off Alzheimer’sMarch 13, 2025
A person’s “bioenergetic age” — or how youthfully their cells generate energy — might be a key indicator of whether they’re at risk of developing Alzheimer’s disease, new research from Weill Cornell Medicine shows.
- Tumor Metabolism Atlas Offers a New Way to Discover Cancer MechanismsJune 29, 2023
An atlas that catalogues gene activity and the levels of small molecules called metabolites in tumor samples offers a new way of identifying the deep mechanisms of cancer, according to researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.
- Alzheimer’s Disease Causes Major Metabolic Changes in the BrainSeptember 14, 2022
A collaboration between Weill Cornell Medicine scientists and other leaders in Alzheimer’s disease research has revealed widespread metabolic changes in the brains of individuals with Alzheimer’s disease.
Mentoring
5 menteesAll publications with mentees →
- MBMustafa BuyukozkanPhysiology, Biophysics & Systems Biology (PhD) · Class of 2022
- ASAnnalise SchweickartTri-I Program in Computational Biology & Medicine · Class of 2024
- NBNicholas BarteloPhysiology, Biophysics & Systems Biology (PhD)
- JCJonathan Chacon-BarahonaTri-I Program in Computational Biology & Medicine (PhD)
- KCKelsey ChetnikPostdoc mentee · 2020–2023
External relationships
Leadership Roles
celeste
Ownership
celeste · Strand Health
Other
celeste · Strand Health